Videos footage from RuCCS Colloquium Talks can be found on the RuCCS YouTube Channel. For all other events, please check the sponsor's website for more detail.
To filter by event category, click on the event category link in the table below or use the menu on the right.
List of Past Events
Invitations to Industry - Eleftheria Pissadaki, Manager, Systems Neuroscientist, Biogen Digital Health at Biogen
Thursday, March 31, 2022, 12:00pm
Dr. Pissadaki is a deep insight visionary interdisciplinary neuroscientist and a multirole research manager, leading research and innovation activities in the fields of neuroscience, complex data analysis, digital medicine and blockchain technology. She has experience gained through appointments in world class universities, IT and pharmaceutical companies fused into skills and profile structured for pushing science and innovation challenges beyond limits and expectations.
Her primal vision is to develop and research ideas, turn them into projects and deliverables, and build organizations for impacting and alleviating suffering in health conditions. Finding out the right space and mission for leading with full dedication on inherently complex problems, while succeeding even when background is limited, or results are deserted. Dr. Pissadaki is an alumna of the University of Crete where she earned her PhD in Computational Neuroscience, Neurobiology and her MS in Neuroscience, Neurobiology, and Neurosciences. She completed her post-doctoral fellowship at the University of Oxford in Neuroscience.
Biogen: "Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit here. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube."
For future Invitations to Industry (i2i) talks, check here.